The Activity of SN33638, an Inhibitor of AKR1C3, on Testosterone and 17ß-Estradiol Production and Function in Castration-Resistant Prostate Cancer and ER-Positive Breast Cancer.

Yin, Yarong Diana; Fu, Melissa; Brooke, Darby G; Heinrich, Daniel M; Denny, William A; Jamieson, Stephen M F

Yin, Yarong Diana; Fu, Melissa; Brooke, Darby G; Heinrich, Daniel M; Denny, William A; Jamieson, Stephen M F.

Afiliación

Yin YD; Auckland Cancer Society Research Centre, The University of Auckland , Auckland , New Zealand.
Fu M; Auckland Cancer Society Research Centre, The University of Auckland , Auckland , New Zealand.
Brooke DG; Auckland Cancer Society Research Centre, The University of Auckland , Auckland , New Zealand.
Heinrich DM; Auckland Cancer Society Research Centre, The University of Auckland , Auckland , New Zealand.
Denny WA; Auckland Cancer Society Research Centre, The University of Auckland , Auckland , New Zealand ; Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland , Auckland , New Zealand.
Jamieson SM; Auckland Cancer Society Research Centre, The University of Auckland , Auckland , New Zealand ; Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland , Auckland , New Zealand.

Front Oncol ; 4: 159, 2014.

Article en En | MEDLINE | ID: mdl-24995161

Palabras clave

11ß-prostaglandin F2α; 17ß-estradiol; AKR1C3; ER-positive breast cancer; SN33638; castration-resistant prostate cancer; prostate-specific antigen; testosterone

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google